Skip to content
healthcare.dev

Ilaris

NDC 0078-0734, canakinumab, injection, solution, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0734
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125319
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0734 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CANAKINUMAB150 mg/mL
Package NDCNDC-11Package
0078-0734-61000780734611 VIAL, SINGLE-USE in 1 CARTON (0078-0734-61) / 1 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7d271f3b-e4f9-4d80-8dcf-28d49123f80e
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0078-0734

Use it

Look up 0078-0734 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0734 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0734. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.